Abstract
Nicotinic acid (NA) decreases low density lipoprotein (LDL) cholesterol and increases highdensity lipoprotein (HDL) cholesterol at pharmacological doses 500-2000 mg/day, which further inhibits the progression of atherosclerosis and cardiovascular morbidity. However, some effects of NA may be mediated through lipid-independent pathways. NA participates in the regulation of glucose metabolism and the NAD-sirtuin pathway, which may relate to the altered mitochondrial biogenesis. NA exerts its anti-atherosclerotic or side effects via binding to GPR109A and receptor TRPV1. NA may regulate lipid metabolism via adipokines, especially TNFα and adiponectin. NA participates in several cellular pathways, including forkhead transcription factors, sirtuins, and protein kinase B. Though much progress on the regulatory effect of NA has been obtained, much remains to be determined about the exact cellular signal pathways on the regulatory mechanism. To reveal the mechanisms of excessive fatty deposition diseases, it is necessary to investigate the signaling pathways in the muscle, liver, and adipose tissue by which NA controls lipid metabolism. In this paper, we will review recent data on the pharmacological effects of NA and discuss how NA might be harnessed to regulate glucose and lipid metabolism through lipid-independent pathways.
Keywords: Adipokine, glucose metabolism, lipid metabolism, nicotinic acid, nicotinamide, receptor GPR109A, regulatory mechanism.
Current Pharmaceutical Biotechnology
Title:Nicotinic Acid Regulates Glucose and Lipid Metabolism Through Lipidindependent Pathways
Volume: 16 Issue: 1
Author(s): Dongwu Liu, Xiaoqian Wang, Ling Kong and Zhiwei Chen
Affiliation:
Keywords: Adipokine, glucose metabolism, lipid metabolism, nicotinic acid, nicotinamide, receptor GPR109A, regulatory mechanism.
Abstract: Nicotinic acid (NA) decreases low density lipoprotein (LDL) cholesterol and increases highdensity lipoprotein (HDL) cholesterol at pharmacological doses 500-2000 mg/day, which further inhibits the progression of atherosclerosis and cardiovascular morbidity. However, some effects of NA may be mediated through lipid-independent pathways. NA participates in the regulation of glucose metabolism and the NAD-sirtuin pathway, which may relate to the altered mitochondrial biogenesis. NA exerts its anti-atherosclerotic or side effects via binding to GPR109A and receptor TRPV1. NA may regulate lipid metabolism via adipokines, especially TNFα and adiponectin. NA participates in several cellular pathways, including forkhead transcription factors, sirtuins, and protein kinase B. Though much progress on the regulatory effect of NA has been obtained, much remains to be determined about the exact cellular signal pathways on the regulatory mechanism. To reveal the mechanisms of excessive fatty deposition diseases, it is necessary to investigate the signaling pathways in the muscle, liver, and adipose tissue by which NA controls lipid metabolism. In this paper, we will review recent data on the pharmacological effects of NA and discuss how NA might be harnessed to regulate glucose and lipid metabolism through lipid-independent pathways.
Export Options
About this article
Cite this article as:
Liu Dongwu, Wang Xiaoqian, Kong Ling and Chen Zhiwei, Nicotinic Acid Regulates Glucose and Lipid Metabolism Through Lipidindependent Pathways, Current Pharmaceutical Biotechnology 2015; 16 (1) . https://dx.doi.org/10.2174/1389201015666141126123401
DOI https://dx.doi.org/10.2174/1389201015666141126123401 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunomodulatory and Anti-Inflammatory Activities of Statins
Endocrine, Metabolic & Immune Disorders - Drug Targets Detection of Melatonin Production from the Intestinal Epithelium Using Electrochemical Methods
Current Pharmaceutical Design Estrogens and Thyroid Hormones: Non-Genomic Effects are Coupled to Transcription
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Relaxin as a Cardiovascular Hormone: Physiology, Pathophysiology and Therapeutic Promises
Cardiovascular & Hematological Agents in Medicinal Chemistry New and Emerging Antiresorptive Treatments in Osteoporosis
Current Drug Safety Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Smad-Signaling in Mammary Gland Development and Tumorigenesis
Current Signal Transduction Therapy Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Justification of Increasing the Blood Flow Velocity in the Arteries of the Thyroid Gland in Autoimmune Thyroiditis as a Reflection of Endothelial Changes Due to Inflammatory Status
Current Medical Imaging Production and Application of Copper Radiopharmaceuticals
Current Radiopharmaceuticals Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders
Current Pharmacogenomics and Personalized Medicine Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease
Current Diabetes Reviews Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17
Anti-Cancer Agents in Medicinal Chemistry Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis
Current Molecular Medicine Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Current Pharmaceutical Design The Signal Pathway of Antibiotic Alternatives on Intestinal Microbiota and Immune Function
Current Protein & Peptide Science New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line
Recent Patents on Anti-Cancer Drug Discovery